Among patients with psoriatic arthritis who received Enbrel, the clinical responses were apparent at the time of the first visit (4 weeks) and were maintained through 6 months of therapy.
Nende psoriaatilise artriidiga patsientide hulgas, kes said Enbreli, oli kliiniline vastus ilmne esimese visiidi ajal (4 nädala jooksul) ning säilis järgneva 6- kuulise ravi kestel.